Cinta Hierro Selected Research

Drug Therapy (Chemotherapy)

2/2024	Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
1/2022	Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going.
4/2019	KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cinta Hierro Research Topics

Disease

15	Neoplasms (Cancer) 02/2024 - 12/2015
2	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 07/2023 - 01/2016
2	Cholangiocarcinoma 01/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2019 - 08/2015
1	Hypoalbuminemia 02/2024
1	Adenocarcinoma 02/2024
1	Thromboembolism 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 04/2019
1	Disease Progression 01/2019
1	Exanthema (Rash) 01/2018
1	Fatigue 01/2018
1	Oncogene Addiction 02/2017

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 10/2022 - 03/2017
2	PlatinumIBA 02/2024 - 04/2019
2	spartalizumabIBA 10/2022 - 01/2021
2	AntibodiesIBA 10/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 10/2022 - 01/2022
2	pembrolizumabIBA 04/2019 - 03/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 12/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 02/2024
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	futibatinibIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	AlbuminsIBA 01/2021
1	erdafitinibIBA 01/2019
1	CH5183284IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	VaccinesIBA 03/2017
1	NivolumabIBA 03/2017
1	atezolizumabIBA 03/2017
1	IpilimumabIBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2015

Therapy/Procedure

6	Therapeutics 02/2024 - 03/2017
6	Immunotherapy 07/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 02/2024 - 04/2019
1	PC protocol 02/2024
1	Drug Tapering 01/2018
1	Combined Modality Therapy 08/2015